SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-18-002117
Filing Date
2018-03-20
Accepted
2018-03-20 16:42:40
Documents
2
Period of Report
2018-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 AYCARDI-FONSECA formthreeaycardi.html 3  
1 FORM 3 AYCARDI-FONSECA formthreeaycardi.xml 3 3507
2 EXHIBIT 24.1 exh_241.htm EX-24.1 5235
  Complete submission text file 0001171843-18-002117.txt   10084
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A0 V5G 48W
Business Address
AYCARDI-FONSECA ERNESTO (Reporting) CIK: 0001734218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 18702298